Revenue and Earnings Growth
Total as reported revenue grew 4%, and constant currency organic revenue grew 6% in the quarter. Adjusted earnings per diluted share from continuing operations was $2.74, a 40% increase over the prior year.
Record Free Cash Flow
Free cash flow for fiscal 2025 was a record $787 million, well above the full-year guidance, driven by significant working capital improvements.
Healthcare Segment Performance
Healthcare constant currency organic revenue grew 6% for the year with margins improving to 25% due to volume, pricing, and productivity.
AST Segment Growth
Constant currency organic revenue for AST grew 9% for the year with 7% growth in services.
Improved Margins in Life Sciences
Margins in Life Sciences increased to 42.3%, a 360 basis point improvement, due to favorable mix, pricing, and divestiture of the CECS business.